J. Pers. Med. 2013, 3(2), 111-123; doi:10.3390/jpm3020111
Article

Physician Awareness and Utilization of Food and Drug Administration (FDA)-Approved Labeling for Pharmacogenomic Testing Information

1 Medco Research Institute, LLC, Medco Health Solutions, Inc., Bethesda, MD 20814, USA 2 EJS Health Solutions, LLC, 1653 Pennfield Drive Thorofare, West Deptford, NJ 08086, USA 3 Biocerna, LLC, Gaithersburg, MD 20879, USA 4 Opus Three, LLC, Gaithersburg, MD 20878, USA
* Author to whom correspondence should be addressed.
Received: 17 April 2013; in revised form: 24 May 2013 / Accepted: 4 June 2013 / Published: 10 June 2013
PDF Full-text Download PDF Full-Text [427 KB, uploaded 10 June 2013 15:29 CEST]
Abstract: We surveyed 10,303 United States physicians on where they obtain pharmacogenomic testing information. Thirty-nine percent indicated that they obtained this from drug labeling. Factors positively associated with this response included older age, postgraduate instruction, using other information sources, regulatory approval/ recommendation of testing, reliance on labeling for information, and perception that patients have benefited from testing. Physicians use pharmacogenomic testing information from drug labeling, highlighting the importance of labeling information that is conducive to practice application.
Keywords: pharmacogenomics; physician; drug labeling; survey

Article Statistics

Load and display the download statistics.

Citations to this Article

Cite This Article

MDPI and ACS Style

Stanek, E.J.; Sanders, C.L.; Frueh, F.W. Physician Awareness and Utilization of Food and Drug Administration (FDA)-Approved Labeling for Pharmacogenomic Testing Information. J. Pers. Med. 2013, 3, 111-123.

AMA Style

Stanek EJ, Sanders CL, Frueh FW. Physician Awareness and Utilization of Food and Drug Administration (FDA)-Approved Labeling for Pharmacogenomic Testing Information. Journal of Personalized Medicine. 2013; 3(2):111-123.

Chicago/Turabian Style

Stanek, Eric J.; Sanders, Christopher L.; Frueh, Felix W. 2013. "Physician Awareness and Utilization of Food and Drug Administration (FDA)-Approved Labeling for Pharmacogenomic Testing Information." J. Pers. Med. 3, no. 2: 111-123.

J. Pers. Med. EISSN 2075-4426 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert